Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
W. J. M. Landman & J. H. H. van Eck. (2017) Coligranulomatosis (Hjärre and Wramby’s disease) reconsidered. Avian Pathology 46:3, pages 237-241.
Read now
Read now
H. J. O'connor. (1994) The Role of Helicobacter pylori in Peptic Ulcer Disease. Scandinavian Journal of Gastroenterology 29:sup201, pages 11-15.
Read now
Read now
T. U. Westblom, E. Madan, M. A. Subik, D. E. Duriex &B. R. Midkiff. (1992) Double-Blind Randomized Trial of Bismuth Subsalicylate and Clindamycin for Treatment of Helicobacter pylori Infection. Scandinavian Journal of Gastroenterology 27:3, pages 249-252.
Read now
Read now
H. G. Desai, H. H. Gill, K. Shankaran, P. R. Mehta & S. R. Prabhu. (1991) Dental Plaque: A Permanent Reservoir of Helicobacter pylori?. Scandinavian Journal of Gastroenterology 26:11, pages 1205-1208.
Read now
Read now
Articles from other publishers (19)
David Y. Graham & Jyh-Ming Liou. (2022) Primer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship. Clinical Gastroenterology and Hepatology 20:5, pages 973-983.e1.
Crossref
Crossref
Maria Pina Dore, Hong Lu & David Y Graham. (2016)
Role of bismuth in improving
Helicobacter pylori
eradication with triple therapy
. Gut 65:5, pages 870-878.
Crossref
Crossref
Javier P. Gisbert, Xavier Calvet, Fernando Bermejo, Daniel Boixeda, Felipe Bory, Luis Bujanda, Manuel Castro-Fernández, Enrique Dominguez-Muñoz, Juan Ignasi Elizalde, Montserrat Forné, Emili Gené, Fernando Gomollón, Ángel Lanas, Carlos Martín de Argila, Adrián G. McNicholl, Fermín Mearin, Javier Molina-Infante, Miguel Montoro, José María Pajares, Angeles Pérez-Aisa, Emilio Pérez-Trallero & Jordi Sánchez-Delgado. (2013) III Conferencia Española de Consenso sobre la infección por Helicobacter pylori. Gastroenterología y Hepatología 36:5, pages 340-374.
Crossref
Crossref
Lori A Fischbach, Karen J Goodman, Mark Feldman & Corinne Aragaki. (2002) Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. International Journal of Epidemiology 31:1, pages 128-139.
Crossref
Crossref
STUART L HAZELL, GEORGE DASKALOPOULOUS, HAZEL M MITCHELL & DAN MASSEY. (2008)
Lansoprazole and amoxycillin: Observations on the treatment of
Helicobacter pylori
infection
. Journal of Gastroenterology and Hepatology 12:2, pages 93-99.
Crossref
Crossref
John CalamJohn Calam. 1996. Clinicians’ Guide to Helicobacter pylori. Clinicians’ Guide to Helicobacter pylori
117
150
.
Eva Buiatti, Nubia Muñoz, Jorge Vivas, Elsa Cano, Simon Peraza, Elsa Carillo, Denis Castro, Victor Sanchez, Olga Andrade, Maja Benz, Silvia de Sanjosé & Walter Oliver. (1994) Difficulty in eradicatingHelicobacter pylori in a population at high risk for stomach cancer in Venezuela. Cancer Causes & Control 5:3, pages 249-254.
Crossref
Crossref
Antonio Tucci, Roberto Corinaldesi, Vincenzo Stanghellini, Giovanni F. Paparo, Stefano Gasperoni, Guido Biasco, Ornella Varoli, Marco Ricci-Maccarini & Luigi Barbara. (1993) One-day therapy for treatment ofHelicobacter pylori infection. Digestive Diseases and Sciences 38:9, pages 1670-1673.
Crossref
Crossref
A M NguyenL EngstrandR M GentaD Y GrahamF A el-Zaatari. (1993) Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction. Journal of Clinical Microbiology 31:4, pages 783-787.
Crossref
Crossref
J. W. FRESTON. (2007) Future prospects for proton pump inhibitors. Alimentary Pharmacology & Therapeutics 7, pages 68-75.
Crossref
Crossref
G. Bisi, L. Accorsi, V. Rollo, G. Merighi & S. Gullini. 1993. Helicobacter pylori and Gastroduodenal Pathology. Helicobacter pylori and Gastroduodenal Pathology
380
384
.
D. Famerée, B. Ramdani & V. Lamy. 1993. Helicobacter pylori and Gastroduodenal Pathology. Helicobacter pylori and Gastroduodenal Pathology
302
304
.
M. López-Brea, E. Martín, C. López-Lavid & J. C. Sanz. (1991) Susceptibility ofHelicobacter pylori to metronidazole. European Journal of Clinical Microbiology & Infectious Diseases 10:12, pages 1082-1083.
Crossref
Crossref
J. D. Harrison, J. A. Jones & D. L. Morris. (1991) Azithromycin levels in plasma and gastric tissue, juice and mucus. European Journal of Clinical Microbiology & Infectious Diseases 10:10, pages 862-864.
Crossref
Crossref
M J PavicićA J van WinkelhoffJ de Graaff. (1991) Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans. Antimicrobial Agents and Chemotherapy 35:5, pages 961-966.
Crossref
Crossref
G. Janus, I. Hammermeister, J.M. Prignet, C. Saccharin, M. Kist & H.K. Koch. (1991) Helicobacter pylori : enquête sérologique chez les militaires du contingent avec étude endoscopique, microbiologique et histologique de 10 sujets à sérologie positive. Médecine et Maladies Infectieuses 21:5, pages 308-312.
Crossref
Crossref
Konstanze Vogt & Helmut Hahn. (1991) Urease Production by Helicobacter (Campylobacter) pylori. Zentralblatt für Bakteriologie 275:1, pages 63-72.
Crossref
Crossref
T. Ulf Westblom & Dennis E. Duriex. (1991) Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Digestive Diseases and Sciences 36:1, pages 25-28.
Crossref
Crossref
T. U. Westblom, S. Gudipati & B. R. Midkiff. (1990) In vitro susceptibility ofHelicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime. European Journal of Clinical Microbiology & Infectious Diseases 9:9, pages 691-693.
Crossref
Crossref